Bixiye
QP91-19 Availity Provider Portal Authorization Tool Enhancements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Natiijooyinka Raadinta
Soo bandhiga 2581 - 2590 ee natiijooyinka 3698
Bixiye
QP97-19 Commercial Product Changes for 2020
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP98-19 Changes to Blue Cross Mailing Addresses
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP90-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: tadalafil
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP89-19 CMS Provider Data Accuracy Audit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP87-19 Medical Drug Exclusion Lists Expanded to Include Triluron – Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP86-19 Pharmacy Benefit Exclusion for Invermectin Cream 1%
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
P23R1-19 Alignment of Start Date for Prior Authorization Requests
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019
Bixiye
QP85-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Sunosi ™
Taariikhda uu dhaqangalayo barnaamijka: Okt 23, 2019
Bixiye
QP82-19 Pharmacy Benefit Update – New Insulin Zero Copay Initiative for Commercial Lines of Business
Taariikhda uu dhaqangalayo barnaamijka: Okt 23, 2019